Tecentriq (atezolizumab) For Treating Bladder Cancer (Urothelial Carcinoma): Side Effects, Cost, And Response Rates Category: Cancer by Lauren Latten, PharmD Intern - June 19, 2016 | Views: 45304 | Likes: 0 | Comment: 0